Prediction of distant metastatic recurrence by tumor-infiltrating lymphocytes in hormone receptor-positive breast cancer.
Koji TakadaShinichiro KashiwagiYuka AsanoWataru GotoRika KouhashiAkimichi YabumotoSae IshiharaTamami MorisakiMasatsune ShibutaniHiroaki TanakaKosei HirakawaMasaichi OhiraPublished in: BMC women's health (2021)
Our findings indicate that TILs may predict distant metastatic recurrence in stages I-II of HR+/HER2- breast cancer in patients who do not undergo chemotherapy.